Marvell Technology, Inc.
MRVL · NASDAQ
Analyst ratings
strong_buy · 26 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 14, 2026 | Keybanc | Maintains | Overweight | $400.00 |
| July 7, 2026 | RBC Capital | Reiterates | Outperform | $360.00 |
| June 29, 2026 | UBS | Maintains | Buy | $340.00 |
| June 29, 2026 | Cantor Fitzgerald | Maintains | Neutral | $300.00 |
| June 24, 2026 | Stifel | Maintains | Buy | $350.00 |
| June 23, 2026 | B of A Securities | Maintains | Buy | $365.00 |
| June 18, 2026 | Keybanc | Maintains | Overweight | $385.00 |
| June 12, 2026 | Rosenblatt | Maintains | Buy | $240.00 |
| June 12, 2026 | B. Riley Securities | Maintains | Buy | $345.00 |
| May 29, 2026 | Barclays | Maintains | Overweight | $275.00 |
| May 28, 2026 | UBS | Maintains | Buy | $230.00 |
| May 28, 2026 | Citigroup | Maintains | Buy | $225.00 |
| May 28, 2026 | Barclays | Maintains | Overweight | $275.00 |
| May 28, 2026 | JP Morgan | Maintains | Overweight | $240.00 |
| May 28, 2026 | Jefferies | Maintains | Buy | $235.00 |
| May 28, 2026 | Roth Capital | Maintains | Buy | $275.00 |
| May 28, 2026 | TD Cowen | Maintains | Hold | $200.00 |
| May 28, 2026 | Oppenheimer | Maintains | Outperform | $250.00 |
| May 28, 2026 | Wells Fargo | Maintains | Overweight | $240.00 |
| May 28, 2026 | Keybanc | Maintains | Overweight | $260.00 |
| May 28, 2026 | Rosenblatt | Maintains | Buy | $240.00 |
| May 28, 2026 | Cantor Fitzgerald | Maintains | Neutral | $220.00 |
| May 28, 2026 | B of A Securities | Maintains | Buy | $240.00 |
| May 28, 2026 | Benchmark | Maintains | Buy | $275.00 |
| May 28, 2026 | Needham | Maintains | Buy | $270.00 |
| May 28, 2026 | Stifel | Maintains | Buy | $230.00 |
| May 28, 2026 | Morgan Stanley | Maintains | Equal-Weight | $195.00 |
| May 26, 2026 | HSBC | Upgrades | Buy | $300.00 |
| May 26, 2026 | Morgan Stanley | Maintains | Equal-Weight | $172.00 |
| May 26, 2026 | Susquehanna | Maintains | Positive | $230.00 |
| May 26, 2026 | Cantor Fitzgerald | Maintains | Neutral | $190.00 |
| May 22, 2026 | Stifel | Maintains | Buy | $210.00 |
| May 21, 2026 | Citigroup | Maintains | Buy | $215.00 |
| May 20, 2026 | Oppenheimer | Maintains | Outperform | $200.00 |
| May 20, 2026 | Wells Fargo | Maintains | Overweight | $195.00 |
| May 19, 2026 | Evercore ISI Group | Maintains | Outperform | $155.00 |
| May 15, 2026 | TD Cowen | Maintains | Hold | $190.00 |
| May 14, 2026 | RBC Capital | Maintains | Outperform | $200.00 |
| May 4, 2026 | UBS | Maintains | Buy | $195.00 |
| April 16, 2026 | Stifel | Maintains | Buy | $140.00 |
| April 15, 2026 | Oppenheimer | Maintains | Outperform | $170.00 |
| April 13, 2026 | B. Riley Securities | Maintains | Buy | $156.00 |
| April 9, 2026 | Cantor Fitzgerald | Maintains | Neutral | $120.00 |
| April 9, 2026 | Barclays | Upgrades | Overweight | $150.00 |
| March 31, 2026 | Benchmark | Reiterates | Buy | $130.00 |
| March 6, 2026 | JP Morgan | Maintains | Overweight | $135.00 |
| March 6, 2026 | Craig-Hallum | Maintains | Buy | $164.00 |
| March 6, 2026 | B. Riley Securities | Reiterates | Buy | $135.00 |
| March 6, 2026 | TD Cowen | Maintains | Hold | $90.00 |
| March 6, 2026 | Citigroup | Maintains | Buy | $118.00 |
| March 6, 2026 | Rosenblatt | Maintains | Buy | $140.00 |
| March 6, 2026 | Morgan Stanley | Maintains | Equal-Weight | $103.00 |
| March 6, 2026 | RBC Capital | Maintains | Outperform | $115.00 |
| March 6, 2026 | Stifel | Maintains | Buy | $120.00 |
| March 6, 2026 | B of A Securities | Upgrades | Buy | $110.00 |
| March 4, 2026 | Evercore ISI Group | Maintains | Outperform | $133.00 |
| March 2, 2026 | Morgan Stanley | Maintains | Equal-Weight | $95.00 |
| February 23, 2026 | UBS | Maintains | Buy | $120.00 |
| February 17, 2026 | Cantor Fitzgerald | Reiterates | Neutral | $100.00 |
| February 3, 2026 | Citigroup | Maintains | Buy | $113.00 |
| February 3, 2026 | UBS | Maintains | Buy | $115.00 |
| February 3, 2026 | Needham | Maintains | Buy | $118.00 |
| February 3, 2026 | Rosenblatt | Maintains | Buy | $115.00 |
| January 7, 2026 | Rosenblatt | Maintains | Buy | $120.00 |
| December 3, 2025 | Barclays | Maintains | Equal-Weight | $105.00 |
| December 3, 2025 | Goldman Sachs | Maintains | Neutral | $90.00 |
| December 3, 2025 | Jefferies | Maintains | Buy | $120.00 |
| December 3, 2025 | B. Riley Securities | Reiterates | Buy | $130.00 |
| December 3, 2025 | Roth Capital | Maintains | Buy | $135.00 |
| December 3, 2025 | Piper Sandler | Reiterates | Overweight | $135.00 |
| December 3, 2025 | Evercore ISI Group | Maintains | Outperform | $156.00 |
| December 3, 2025 | Oppenheimer | Reiterates | Outperform | $150.00 |
| December 3, 2025 | Stifel | Maintains | Buy | $114.00 |
| December 3, 2025 | Susquehanna | Maintains | Positive | $120.00 |
| December 3, 2025 | JP Morgan | Maintains | Overweight | $130.00 |
| December 3, 2025 | Keybanc | Maintains | Overweight | $130.00 |
| December 3, 2025 | Deutsche Bank | Maintains | Buy | $125.00 |
| December 3, 2025 | Wells Fargo | Maintains | Overweight | $135.00 |
| December 3, 2025 | Rosenblatt | Maintains | Buy | $120.00 |
| December 3, 2025 | Benchmark | Maintains | Buy | $130.00 |
| December 3, 2025 | Needham | Maintains | Buy | $120.00 |
| December 1, 2025 | Morgan Stanley | Maintains | Equal-Weight | $86.00 |
| December 1, 2025 | Rosenblatt | Maintains | Buy | $95.00 |
| November 25, 2025 | Susquehanna | Maintains | Positive | $100.00 |
| November 24, 2025 | UBS | Maintains | Buy | $110.00 |
| November 18, 2025 | Goldman Sachs | Maintains | Neutral | $80.00 |
| October 20, 2025 | Barclays | Downgrades | Equal-Weight | $80.00 |
| October 13, 2025 | UBS | Maintains | Buy | $105.00 |
| October 10, 2025 | Oppenheimer | Maintains | Outperform | $115.00 |
| October 1, 2025 | TD Cowen | Downgrades | Hold | $85.00 |
| September 25, 2025 | Needham | Maintains | Buy | $95.00 |
| September 25, 2025 | Deutsche Bank | Maintains | Buy | $90.00 |
Custom XPU program sustainability and long-term revenue visibility
Marvell has issued four consecutive multi-billion-dollar guidance upgrades, raising fiscal 2027 revenue guidance to ~$11.5 billion and fiscal 2028 to ~$16.5 billion. A $1 billion capacity prepayment signals strong customer commitment, with the custom XPU program targeting $10 billion in revenue by fiscal 2029, reinforcing long-term AI infrastructure demand.
KeyBanc explicitly flagged that long-term sustainability of custom XPUs remains uncertain, noting that shifts in data center architecture could undermine this revenue stream. The firm argued that Marvell's optical networking business is more durable and resilient than the headline custom AI chip program over a longer horizon.
Valuation versus growth trajectory — is Marvell priced for perfection?
Bank of America raised its price target to $365, while KeyBanc set a Street-high target of $400, citing expanding data center networking opportunities and a broader semiconductor addressable market revised upward to $2.7 trillion. UBS also raised its target to $340, reflecting broad institutional conviction in Marvell's AI-driven growth.
Marvell trades at approximately 54x NTM EV/EBITDA and 69x NTM P/E, levels that leave little room for execution missteps. The consensus analyst price target of ~$253 sits well below the current trading price, reflecting deep disagreement on whether the company's accelerating story can justify such a premium valuation once index-rebalance buying clears.
CFO transition and its implications for financial disclosure and guidance credibility
Despite the incumbent CFO's resignation, analysts broadly characterize the transition as orderly and driven by macro sentiment rather than any fundamental deterioration in the business. Marvell's consistent guidance raises and strong Q1 results — including record revenue of $2.418 billion — suggest the leadership change has not disrupted execution.
The CFO departure introduces uncertainty around future disclosure consistency at a critical juncture, when Marvell is managing rapid growth and multi-year guidance commitments. Analysts caution that investors should closely monitor whether the new CFO maintains the same level of transparency, particularly regarding the ambitious fiscal 2028 and 2029 revenue targets.